2. Catching a Canadian pharmacy kingpin

When Canadian Internet pharmacies first appeared on the scene in about 2000, they were more irritation than international issue. They mostly filled prescriptions for U.S. retirees lacking health insurance with cheaper drugs from Canada's price-controlled pharmacies.

In 2006, after U.S. authorities had taken a particular interest in Andrew Strempler, he sold his business, RxNorth.com, to competitor Kris Thorkelson, owner of CanadaDrugs.com. Strempler then high-tailed it to the Caribbean.

When Strempler showed up in Miami in June, law enforcement snatched him up. An indictment, unsealed after his arrest, says Strempler shipped to U.S. consumers counterfeit and misbranded drugs between early 2005 and the summer of 2006. It apparently provided a pretty good living because authorities initially wanted him to forfeit $95 million. In October he pleaded guilty and agreed to forfeit $300,000 and faces up to 5 years in jail.

2. Catching a Canadian pharmacy kingpin
Read more on

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.